PCSK9 Inhibition After Heart Transplantation
Condition:   Vasculopathy Interventions:   Biological: alirocumab;   Biological: placebo Sponsors:   Stanford University;   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 25, 2018 Category: Research Source Type: clinical trials

Can Timed Performance Tests be Used to Determine Exercise Capacity in Lung Transplantation Candidates?
Conditions:   Pulmonary Rehabilitation;   Exercise Capacity;   Exercise Test Intervention:   Other: Pulmonary Rehabilitation group Sponsor:   Istanbul Medipol University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 21, 2018 Category: Research Source Type: clinical trials

Can Timed Performance Tests be Used to Determine Exercise Capacity in Lung Transplantation Candidates?
Conditions:   Pulmonary Rehabilitation;   Exercise Capacity;   Exercise Test Intervention:   Other: Pulmonary Rehabilitation Sponsor:   Istanbul Medipol University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 21, 2018 Category: Research Source Type: clinical trials

The Effect of Pulmonary Rehabilitation on Cognitive Status in Lung Transplantation Candidates
Conditions:   Cognitive Impairment;   Pulmonary Rehabilitation Intervention:   Other: Pulmonary Rehabilitation Sponsor:   Istanbul Medipol University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 17, 2018 Category: Research Source Type: clinical trials

A Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With Mavyret
Condition:   Hepatitis C Intervention:   Drug: Mavyret Sponsor:   New York University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 14, 2018 Category: Research Source Type: clinical trials

A Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With Mavyret
Condition:   Hepatitis C Intervention:   Drug: Mavyret Sponsor:   New York University School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 14, 2018 Category: Research Source Type: clinical trials

A Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With Mavyret
Condition:   Hepatitis C Intervention:   Drug: Mavyret Sponsor:   New York University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 14, 2018 Category: Research Source Type: clinical trials

Haplo-Identical Transplantation for Severe Aplastic Anemia and Hypo-Plastic MDS Using Peripheral Blood Stem Cells and Post-Transplant Cyclophosphamide for GVHD Prophylaxis
Conditions:   Severe Aplastic Anemia (SAA);   Hypo-Plastic Myelodysplastic Syndrome (MDS) Intervention:   Procedure: haplo-identical transplantation Sponsor:   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2018 Category: Research Source Type: clinical trials

The Effects of IMT on Exercise Capacity, Dyspnea and Lung Functions in LTx
Conditions:   Lung Transplant;   Inspiratory Muscle Training Interventions:   Other: inspiratory muscle training;   Other: Pulmonary rehabilitation Sponsor:   Istanbul Medipol University Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2018 Category: Research Source Type: clinical trials